Healthcare resource utilization by Respiratory Syncytial Virus disease patients

被引:0
|
作者
Wandstrat, TL
Kaplan-Machlis, B
Beane, J
Dingivan, CA
机构
[1] W Virginia Univ, Charleston, WV 25304 USA
[2] Medimmune Inc, Gaithersburg, MD 20878 USA
关键词
Respiratory Syncytial Virus; RSV; Respigam; RSVIG-IV; premature infant;
D O I
10.1203/00006450-199904020-01054
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
1037
引用
收藏
页码:177A / 177A
页数:1
相关论文
共 50 条
  • [31] Palivizumab prophylaxis for respiratory syncytial virus in Canada:: utilization and outcomes
    Oh, PI
    Lanctôt, KL
    Yoon, A
    Lee, DSC
    Paes, BA
    Simmons, BS
    Parison, D
    Manzi, P
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (06) : 512 - 518
  • [32] Respiratory Syncytial Virus and US Pediatric Intensive Care Utilization
    Shanklin, Alice
    Olson, Taylor
    Patel, Anita K.
    Rivera, Eduardo A. Trujillo
    Pollack, Murray M.
    JAMA NETWORK OPEN, 2024, 7 (10)
  • [33] Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis
    Caroline Amand
    Sabine Tong
    Alexia Kieffer
    Moe H. Kyaw
    BMC Health Services Research, 18
  • [34] Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease
    Simoes, EAF
    Sondheimer, HM
    Top, FH
    Meissner, HC
    Welliver, RC
    Kramer, AA
    Groothuis, JR
    JOURNAL OF PEDIATRICS, 1998, 133 (04): : 492 - 499
  • [35] Healthcare resource utilisation and costs in infants with confirmed respiratory syncytial virus infections: a national population cohort study
    Han, Hyun Jin
    Ryu, Dahye
    Kim, Ju Young
    Jang, Semin
    Suh, Hae Sun
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [36] Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis
    Amand, Caroline
    Tong, Sabine
    Kieffer, Alexia
    Kyaw, Moe H.
    BMC HEALTH SERVICES RESEARCH, 2018, 18
  • [37] The Respiratory Mucosa: Front and Center in Respiratory Syncytial Virus Disease
    Thwaites, Ryan S.
    Openshaw, Peter J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 200 (11) : 1340 - 1342
  • [38] Utilization pattern of chronic lung disease treatment prior to the start of respiratory syncytial virus season
    Choi, Yoonyoung
    Meissner, H. Cody
    Hampp, Christian
    Park, Haesuk
    Brumback, Babett
    Winterstein, Almut G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 543 - 544
  • [39] Respiratory syncytial virus immunoglobulin as prophylaxis against respiratory syncytial virus in children with congenital heart disease.
    Simoes, EAF
    Sondheimer, HM
    Meissner, HC
    Welliver, RC
    Groothuis, JR
    PEDIATRIC RESEARCH, 1996, 39 (04) : 662 - 662
  • [40] Healthcare resource utilization among patients with cold agglutinin disease in Denmark
    Vago, Emese K.
    Nicholson, Gina
    Horvath-Puho, Erzsebet
    Hooda, Naushin
    Fryzek, Jon P.
    Su, Jun
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (10) : 1829 - 1835